Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 4

1.

Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer.

Carver BS, Chapinski C, Wongvipat J, Hieronymus H, Chen Y, Chandarlapaty S, Arora VK, Le C, Koutcher J, Scher H, Scardino PT, Rosen N, Sawyers CL.

Cancer Cell. 2011 May 17;19(5):575-86. doi: 10.1016/j.ccr.2011.04.008.

2.

Cross-talk between the androgen receptor and the phosphatidylinositol 3-kinase/Akt pathway in prostate cancer.

Wang Y, Kreisberg JI, Ghosh PM.

Curr Cancer Drug Targets. 2007 Sep;7(6):591-604. Review.

PMID:
17896924
3.

Targeting the PI3K/AKT pathway for the treatment of prostate cancer.

Sarker D, Reid AH, Yap TA, de Bono JS.

Clin Cancer Res. 2009 Aug 1;15(15):4799-805. doi: 10.1158/1078-0432.CCR-08-0125. Epub 2009 Jul 28. Review.

4.

The PI3K/AKT pathway in the pathogenesis of prostate cancer.

Chen H, Zhou L, Wu X, Li R, Wen J, Sha J, Wen X.

Front Biosci (Landmark Ed). 2016 Jun 1;21:1084-91. Review.

PMID:
27100493

Supplemental Content

Support Center